Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

18 Dec 2018 11:47

RNS Number : 8456K
GoldmanSachs International
18 December 2018
 

 

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SHIRE PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

SHIRE PLC

(d) Date dealing undertaken:

17 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - disclosed previously for TAKEDA PHARMACEUTICAL COMPANY LIMITED

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Purchases

3,194,065142,783

46.4350 GBP58.7335 USD

45.1050 GBP57.0060 USD

Ordinary

Sales

3,199,495385,700

46.4751 GBP58.6562 USD

45.0850 GBP58.6182 USD

ADR / (1.00 : 3.00)

Purchases

2,400 (7,200)

171.5000 USD

170.5600 USD

ADR / (1.00 : 3.00)

Sales

600 (1,800)

171.5000 USD

171.5000 USD

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary

CFD

Reducing a short position

9,983

45.2616 GBP

Ordinary

CFD

Opening a long position

9,403

45.2616 GBP

Ordinary

CFD

Opening a short position

25,944

45.2627 GBP

Ordinary

CFD

Opening a short position

25,400

45.2695 GBP

Ordinary

CFD

Reducing a short position

2,633

45.2696 GBP

Ordinary

CFD

Opening a short position

13,789

45.2706 GBP

Ordinary

CFD

Opening a short position

71,750

45.2730 GBP

Ordinary

CFD

Increasing a long position

18,000

45.2887 GBP

Ordinary

CFD

Opening a long position

18,000

45.2887 GBP

Ordinary

CFD

Opening a long position

87,716

45.3075 GBP

Ordinary

CFD

Reducing a short position

5,322

45.3086 GBP

Ordinary

CFD

Reducing a short position

3,750

45.3100 GBP

Ordinary

CFD

Reducing a short position

3,515

45.3250 GBP

Ordinary

CFD

Reducing a short position

3,467

45.3250 GBP

Ordinary

CFD

Opening a long position

2,206

45.3250 GBP

Ordinary

CFD

Reducing a long position

306

45.3913 GBP

Ordinary

CFD

Reducing a long position

804

45.3913 GBP

Ordinary

CFD

Reducing a long position

46

45.3913 GBP

Ordinary

CFD

Reducing a long position

720

45.3913 GBP

Ordinary

CFD

Reducing a long position

156

45.3913 GBP

Ordinary

CFD

Reducing a long position

194

45.3913 GBP

Ordinary

CFD

Increasing a short position

961

45.4130 GBP

Ordinary

CFD

Reducing a long position

41,493

45.4200 GBP

Ordinary

CFD

Reducing a long position

2,206

45.4312 GBP

Ordinary

CFD

Reducing a long position

306

45.4775 GBP

Ordinary

CFD

Reducing a long position

801

45.4775 GBP

Ordinary

CFD

Reducing a long position

47

45.4775 GBP

Ordinary

CFD

Reducing a long position

717

45.4775 GBP

Ordinary

CFD

Reducing a long position

155

45.4775 GBP

Ordinary

CFD

Reducing a long position

193

45.4775 GBP

Ordinary

CFD

Opening a long position

1,000

45.4800 GBP

Ordinary

CFD

Reducing a long position

1,000

45.4800 GBP

Ordinary

CFD

Increasing a short position

10,000

45.4983 GBP

Ordinary

CFD

Reducing a long position

27,000

45.7484 GBP

Ordinary

CFD

Increasing a long position

77

45.7988 GBP

Ordinary

CFD

Increasing a long position

357

45.7988 GBP

Ordinary

CFD

Increasing a long position

152

45.7988 GBP

Ordinary

CFD

Increasing a long position

96

45.7988 GBP

Ordinary

CFD

Increasing a long position

398

45.7988 GBP

Ordinary

CFD

Increasing a long position

23

45.7988 GBP

Ordinary

CFD

Opening a short position

88,000

45.9484 GBP

Ordinary

CFD

Increasing a long position

153

46.1349 GBP

Ordinary

CFD

Increasing a long position

706

46.1349 GBP

Ordinary

CFD

Increasing a long position

301

46.1349 GBP

Ordinary

CFD

Increasing a long position

191

46.1349 GBP

Ordinary

CFD

Increasing a long position

790

46.1349 GBP

Ordinary

CFD

Increasing a long position

46

46.1349 GBP

Ordinary

CFD

Opening a long position

378

46.2463 GBP

Ordinary

CFD

Opening a long position

471

46.2463 GBP

Ordinary

CFD

Opening a long position

1,747

46.2463 GBP

Ordinary

CFD

Opening a long position

113

46.2463 GBP

Ordinary

CFD

Opening a long position

744

46.2463 GBP

Ordinary

CFD

Opening a long position

1,951

46.2463 GBP

Ordinary

CFD

Reducing a long position

8,615

46.2500 GBP

Ordinary

CFD

Increasing a long position

9,000

46.2893 GBP

Ordinary

CFD

Increasing a long position

152

46.3808 GBP

Ordinary

CFD

Increasing a long position

705

46.3808 GBP

Ordinary

CFD

Increasing a long position

300

46.3808 GBP

Ordinary

CFD

Increasing a long position

189

46.3808 GBP

Ordinary

CFD

Increasing a long position

786

46.3808 GBP

Ordinary

CFD

Increasing a long position

45

46.3808 GBP

Ordinary

CFD

Opening a short position

2,839

57.0060 USD

Ordinary

CFD

Opening a short position

7,161

57.0060 USD

Ordinary

CFD

Opening a short position

300

57.3100 USD

Ordinary

CFD

Opening a short position

1,907

57.3100 USD

Ordinary

CFD

Opening a short position

4,078

57.3100 USD

Ordinary

CFD

Opening a short position

909

57.3100 USD

Ordinary

CFD

Increasing a short position

3,230

57.3661 USD

Ordinary

CFD

Increasing a short position

52,530

57.3661 USD

Ordinary

CFD

Increasing a short position

29,240

57.3661 USD

Ordinary

CFD

Opening a short position

3,913

57.4081 USD

Ordinary

CFD

Opening a short position

1,819

57.4081 USD

Ordinary

CFD

Opening a short position

600

57.4081 USD

Ordinary

CFD

Opening a short position

8,257

57.4081 USD

Ordinary

CFD

Opening a short position

14,322

57.6583 USD

Ordinary

CFD

Opening a short position

5,678

57.6583 USD

Ordinary

CFD

Opening a short position

6,000

58.7335 USD

Ordinary

SWAP

Opening a long position

50,000

45.2983 GBP

Ordinary

SWAP

Reducing a short position

10,320

45.4255 GBP

Ordinary

SWAP

Opening a short position

3,290

46.7300 GBP

Ordinary

SWAP

Reducing a short position

3,220

46.7300 GBP

Ordinary

SWAP

Reducing a short position

2,200

46.7300 GBP

Ordinary

SWAP

Opening a short position

200

46.7300 GBP

Ordinary

SWAP

Opening a short position

720

46.7300 GBP

Ordinary

SWAP

Opening a short position

1,210

46.7300 GBP

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

6 (1,800)

172.5000 USD

AMERICAN

21/12/2018

1.1000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

5 (1,500)

172.5000 USD

AMERICAN

21/12/2018

1.3460 USD

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

18 December 2018

Contact name:

Kashif Rafiq and Papa Lette

Telephone number:

+44(20) 7051 0547 / +44(20) 7774 7442

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERBBBDDUSBBGII
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.